As seen on the volcano plot and OncoPrint in Figure 3A, EGFR and TP53 were found to be enriched in the KRASG12C wild-type lung cancer while STK11 was a more common co-occurring mutation in KRASG12C-mutant lung cancer. Here, TP53 is linked to lung carcinoma.